Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Commonly available blood-pressure medication prevents epilepsy after severe brain injury

  • Critical new protein complex involved in learning, memory

  • Teachers' scare tactics may lead to lower exam scores

  • Financial incentives help economically-disadvantaged pregnant smokers quit, improve fetal growth

  • Regulating legal marijuana could be guided by lessons from alcohol, tobacco, study says

  • Want to quit smoking? New study says try 'self-expanding' activities

  • Mentor programs harm, more than help first-year teachers

  • Physicists push new Parkinson's treatment toward clinical trials

  • First brain images of African infants enable research into cognitive effects of nutrition

  • New way to enhance nerve growth following injury discovered

  •